Antibiotics can increase appetite through several overlapping mechanisms, though the effect varies widely depending on the drug, the person, and how long the course lasts. The most well-understood pathways involve disruption of gut bacteria that normally help regulate hunger signals, and in the case of one antibiotic class, a direct stimulation of the gut’s own hunger machinery. The picture is messier than a single cause-and-effect story, and in some people antibiotics actually suppress appetite instead.
How Gut Bacteria Normally Help Control Hunger
Your intestinal bacteria do more than digest fiber. Certain species ferment dietary components into short-chain fatty acids, small molecules that serve as chemical messengers between your gut and your brain. One of these fatty acids, propionate, triggers specialized cells in the colon to release two satiety hormones: GLP-1 and PYY. In animal studies, infusing propionate directly into the colon raised blood levels of both hormones, and the effect depended on a specific receptor called FFA2. When that receptor was knocked out in mice, propionate stopped triggering the hormone release.
This matters for antibiotics because a broad-spectrum course can wipe out large populations of the bacteria responsible for producing these fatty acids. With fewer short-chain fatty acids reaching colonic cells, the steady background signal telling your brain “you’ve had enough” gets quieter. The result is not dramatic starvation-level hunger in most people, but it can shift the balance just enough that you feel less satisfied after meals or find yourself reaching for snacks more often. Probiotics have shown some ability to restore short-chain fatty acid production after disruption, which is one reason clinicians sometimes recommend them during or after antibiotic treatment.
The Erythromycin Exception
Most antibiotics affect appetite indirectly, through the microbiome. Erythromycin is different. This macrolide antibiotic happens to mimic a gut hormone called motilin, which triggers a specific pattern of stomach contractions known as the migrating motor complex. These contractions normally sweep through the stomach and small intestine between meals, and they are closely linked to the sensation of hunger. When erythromycin binds to motilin receptors, it kicks off premature rounds of these contractions, essentially tricking the stomach into behaving as though it has been empty for hours.
Research has confirmed that erythromycin-induced contractions stimulate hunger feelings through a pathway involving the vagus nerve and acetylcholine signaling. More than just creating the sensation of hunger, the drug appears to increase actual food intake, suggesting that motilin functions as a genuine appetite-stimulating signal from the gastrointestinal tract. This is a pharmacological side effect rather than a microbiome-mediated one, and it kicks in quickly, sometimes within hours of taking the drug. Other macrolide antibiotics share some structural similarity to erythromycin, but the motilin-agonist effect is strongest with erythromycin itself.
Gastroenterologists have actually exploited this side effect therapeutically. In patients with gastroparesis, where the stomach empties too slowly, low doses of erythromycin are sometimes prescribed specifically to stimulate motility. The appetite boost is a side effect for most people but a feature for those who need it.
Ghrelin and the Gut-Brain Axis
Ghrelin is often called the hunger hormone because it rises before meals and drops after eating. It is produced mainly in the stomach, and its levels are sensitive to changes in the gut environment. Antibiotic-induced changes in ghrelin have been documented, though the direction of change is not always consistent. A study examining patients who underwent antibiotic therapy to eradicate the stomach bacterium H. pylori found that fasting ghrelin levels actually fell after treatment, dropping from roughly 18 to 13 picograms per milliliter. That result seems counterintuitive if we are talking about increased appetite, but it highlights an important nuance: the specific bacteria being killed, the antibiotic combination used, and the baseline state of the gut all influence which direction hormone levels move.
More broadly, researchers have observed that antibiotic-induced disruption of the microbiome can cause ghrelin fluctuations that alter hunger cues, fat metabolism, and even heat production in the body. The gut-brain axis, the communication highway between intestinal microbes and the central nervous system, relies on hormones like ghrelin and on neuroactive compounds that bacteria themselves produce. When antibiotics scramble that communication network, the downstream effects can include not just changed appetite but also mood shifts and altered behavior, though most people on a short antibiotic course will notice only subtle changes, if any.
Bile Acids Add Another Layer
Gut bacteria play a major role in transforming bile acids, the compounds your liver makes to help digest fat. When antibiotics knock back the bacterial populations responsible for these transformations, the composition of bile acids in your blood changes. Research in animal models has shown that antibiotic-driven shifts in bile acid profiles correlate closely with metabolic changes, partly through a receptor called TGR5 that regulates energy expenditure and glucose handling. Treating animals with a compound that activates TGR5 partially recreated the metabolic effects seen after antibiotic treatment, suggesting that the bile acid pathway is a genuine mediator of how antibiotics alter metabolism, not just a bystander.
What makes this mechanism relevant to appetite is that bile acid signaling influences how efficiently your body extracts energy from food and how it partitions that energy between storage and use. A shift toward more efficient energy extraction could, in theory, promote weight gain even without a dramatic increase in how much you eat. The practical significance for a person finishing a week of amoxicillin is probably small, but in prolonged or repeated antibiotic exposure, these metabolic shifts may accumulate.
What Livestock Farming Taught Us
Long before anyone mapped the human microbiome, farmers discovered that feeding low doses of antibiotics to poultry and livestock made the animals grow faster on less feed. This practice, widespread since the mid-twentieth century, provided some of the earliest indirect evidence that antibiotics change how bodies process food. Studies in poultry confirmed that several antibiotics, including penicillin, bacitracin, and lincomycin, improved weight gain and feed efficiency while simultaneously reducing the activity of bacterial enzymes that transform bile acids in the small intestine. That bile acid connection echoes the findings in the human-focused research described above, suggesting a shared mechanism across species.
The agricultural parallel is not a perfect map onto what happens in a person taking a ten-day course of antibiotics for a sinus infection. Farm animals received subtherapeutic doses continuously, sometimes for their entire lives, which is a very different exposure pattern. Still, the consistency of the weight-gain effect across different antibiotic classes and animal species raised alarm bells that eventually contributed to regulations restricting antibiotic use in agriculture in many countries. It also planted the idea that the same process could operate in humans, particularly in children exposed to antibiotics during early development.
Does Early Antibiotic Exposure Cause Weight Gain in Children?
The livestock evidence fueled widespread concern that giving antibiotics to infants and young children might predispose them to obesity. Several observational studies reported associations between early antibiotic use and higher body weight later in childhood, and the idea gained traction in both medical literature and popular health media. But the picture turned out to be more complicated than the headlines suggested.
A carefully designed study that followed children from birth and also examined twins, where one twin received antibiotics in the first six months of life and the other did not, found no significant association between antibiotic exposure and weight change. The exposed children gained an estimated extra 50 grams between ages two and five, a difference that was not statistically meaningful. Among the twin pairs, the antibiotic-exposed twin actually weighed slightly less, not more, than the unexposed sibling, and again the difference was not significant. This does not definitively close the question, because the study tracked relatively short-term outcomes and used a specific age window. But it does suggest that the worry about a single early antibiotic course permanently resetting a child’s weight trajectory has been overstated.
The disconnect between the dramatic livestock results and the modest human findings probably comes down to dose, duration, and timing. Farm animals received continuous low-dose exposure specifically chosen to maximize growth. A baby getting a five-day course of amoxicillin for an ear infection is in a very different situation. Repeated courses over several years during critical developmental windows might still matter, but the evidence is weaker than the early alarm suggested.
When Antibiotics Kill Your Appetite Instead
For every person who notices increased hunger on antibiotics, there is someone else who cannot stand the sight of food. Nausea, abdominal cramping, and diarrhea are among the most common antibiotic side effects, and they can suppress appetite far more powerfully than any microbiome disruption could enhance it. The reason the appetite-boosting mechanisms get less attention in everyday clinical practice is that they tend to be subtle and slow, while the appetite-suppressing effects are immediate and obvious.
There is also a less recognized pathway: some antibiotics directly alter taste and smell. An analysis of adverse-event reports found that at least six antibiotic drugs were associated with taste and smell disturbances, with symptoms typically appearing within two to five days of starting the medication. These disturbances included metallic taste, reduced ability to taste food, and altered smell perception. For some people, these changes make food less appealing, which overrides any metabolic signal pushing them to eat more. The association held even for drugs whose official prescribing information did not list taste changes as a known side effect, suggesting the problem is underrecognized.
The interplay between these competing forces explains why the question “do antibiotics increase appetite” does not have a clean yes-or-no answer. Whether you personally feel hungrier on antibiotics depends on which drug you are taking, how your individual microbiome responds, whether you are experiencing gastrointestinal side effects, and how sensitive your taste and smell receptors are to the particular compound.
Recovery, and Whether to Do Anything About It
If you do notice increased hunger during or after an antibiotic course, the effect is usually temporary. The gut microbiome starts recovering within days of stopping the medication, though full restoration to the pre-antibiotic state can take weeks to months depending on the drug and the person. As bacterial populations rebound, short-chain fatty acid production ramps back up, satiety hormone signaling normalizes, and bile acid metabolism shifts back toward its baseline pattern.
Probiotics are often recommended to speed this recovery, and there is a biological rationale for the advice. Probiotic bacteria can contribute to short-chain fatty acid production and help re-establish microbial diversity. The evidence that probiotic supplementation during antibiotics specifically prevents appetite changes is thin, but the broader evidence that probiotics support microbiome recovery is more established. Eating a fiber-rich diet during and after antibiotics also makes sense, since dietary fiber is the raw material that gut bacteria ferment into the short-chain fatty acids that drive satiety signaling.
For the erythromycin-specific motilin effect, there is no dietary workaround. The hunger stimulus is pharmacological, not microbiome-mediated, and it resolves when you stop the drug. If you are on erythromycin and finding the hunger spikes disruptive, that is worth mentioning to your prescriber, since alternative antibiotics in the same class may produce less motilin stimulation.
Why This Effect Flew Under the Radar
Antibiotics are typically prescribed for short courses to treat acute infections, and any appetite change gets buried under the more pressing concern of getting better. Patients who feel hungrier often attribute it to recovering from illness, which is a reasonable assumption since infection itself suppresses appetite through inflammatory signaling. The rebound in hunger as you start to feel better can easily be mistaken for, or blended with, a genuine antibiotic-driven appetite increase. Clinicians rarely ask about appetite changes during antibiotic follow-ups, and patients rarely volunteer the information because it does not feel like a “real” side effect compared to diarrhea or a rash.
The research itself has also been fragmented. The motilin-agonist work sits in gastroenterology journals. The microbiome-hormone research lives in metabolic and endocrine publications. The bile acid findings come from yet another silo. No single field has owned the question of antibiotic-driven appetite change, which means no single review has pulled all the threads together in a way that would filter into clinical guidelines. The closest thing to a unifying framework comes from the agricultural literature, where the practical consequences were too economically significant to ignore, and from the growing field of microbiome science, which has given researchers the tools to trace these effects back to specific bacterial populations and their metabolic products.